Momordica charantia seed extract exhibits strong anticoagulant effect by specifically interfering in intrinsic pathway of blood coagulation and dissolves fibrin clot

Manjappa, B. and Gangaraju, S. and Girish, K. S. and Kemparaju, K. and Gonchigar, S. J. and Shankar, R. L. and Shinde, M. and Sannaningaiah, D. (2015) Momordica charantia seed extract exhibits strong anticoagulant effect by specifically interfering in intrinsic pathway of blood coagulation and dissolves fibrin clot. BLOOD COAGULATION & FIBRINOLYSIS, 26 (2). pp. 191-199. ISSN 1473-5733

Full text not available from this repository. (Request a copy)
Official URL: https://doi.org/10.1097/MBC.0000000000000191

Abstract

The current study explores the anticoagulant and fibrin clot-hydrolyzing properties of Momordica charantia seed extract (MCSE). MCSE hydrolyzed casein with the specific activity of 0.780 units/mg per min. Interestingly, it enhanced the clot formation process of citrated human plasma from control 146 to 432 s. In addition, the intravenous injection of MCSE significantly prolonged the bleeding time in a dose-dependent manner from control 150 to more than 800 s, and strengthened its anticoagulant activity. Interestingly, MCSE specifically prolonged the clotting time of only activated partial thromboplastin time, but not prothrombin time, and revealed the participation of MCSE in the intrinsic pathway of the blood coagulation cascade. Furthermore, MCSE completely hydrolyzed both A alpha and B beta chains of the human fibrinogen and partially hydrolyzed the gamma chain. However, it hydrolyzed all the chains (alpha polymer, alpha chain, beta chain and gamma-gamma dimmers) of partially cross-linked human fibrin clot. The proteolytic activity followed by the anticoagulant effect of the MCSE was completely abolished by the 1,10-phenanthroline and phenyl methyl sulphonyl fluoride, but iodoacetic acid, EDTA, and ethylene glycol-N, N, N', N'-tetra acetic acid did not. Curiously, MCSE did not hydrolyze any other plasma proteins except the plasma fibrinogen. Moreover, MCSE was devoid of RBC lysis, edema and hemorrhagic properties, suggesting its nontoxic nature. Taken together, MCSE may be a valuable candidate in the treatment of blood clot/thrombotic disorders. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.

Item Type: Article
Subjects: C Chemical Science > Biochemistry
Divisions: Department of > Biochemistry
Depositing User: Shrirekha N
Date Deposited: 14 Jun 2019 09:18
Last Modified: 14 Jun 2019 09:18
URI: http://eprints.uni-mysore.ac.in/id/eprint/2782

Actions (login required)

View Item View Item